Interestingly, the expression of DNMT1 and UHRF1 were found to be sensitive to the MEK inhibitors in cancer cells33, suggesting that the EGRF pathway plays a role in sustaining the expression of these two regulators. The gene discussed is UHRF1; the disease is cancer.